TCI Wealth Advisors, Inc. - SANGAMO THERAPEUTICS INC ownership

SANGAMO THERAPEUTICS INC's ticker is SGMO and the CUSIP is 800677106. A total of 172 filers reported holding SANGAMO THERAPEUTICS INC in Q4 2017. The put-call ratio across all filers is 0.73 and the average weighting 0.1%.

Quarter-by-quarter ownership
TCI Wealth Advisors, Inc. ownership history of SANGAMO THERAPEUTICS INC
ValueSharesWeighting
Q1 2023$3,005
+91.4%
1,707
+241.4%
0.00%
Q4 2022$1,570
-77.6%
500
-62.3%
0.00%
-100.0%
Q3 2022$7,000
+40.0%
1,3280.0%0.00%0.0%
Q2 2022$5,000
+66.7%
1,328
+165.6%
0.00%
Q1 2022$3,0000.0%500
+25.0%
0.00%
Q4 2021$3,000
-40.0%
400
-33.3%
0.00%
-100.0%
Q3 2021$5,000
-58.3%
600
-38.9%
0.00%
-50.0%
Q2 2021$12,000
-33.3%
982
-33.0%
0.00%
-75.0%
Q1 2021$18,000
-10.0%
1,466
+12.8%
0.01%
-11.1%
Q4 2020$20,000
-23.1%
1,300
-51.9%
0.01%
-10.0%
Q3 2020$26,000
+4.0%
2,700
-3.6%
0.01%
-9.1%
Q2 2020$25,000
+38.9%
2,8000.0%0.01%
+22.2%
Q1 2020$18,000
-18.2%
2,800
+7.7%
0.01%0.0%
Q4 2019$22,000
-35.3%
2,600
-31.6%
0.01%
-40.0%
Q3 2019$34,000
-12.8%
3,800
+5.6%
0.02%
-16.7%
Q2 2019$39,000
+18.2%
3,600
+2.9%
0.02%
+20.0%
Q1 2019$33,000
-15.4%
3,500
+2.9%
0.02%
-21.1%
Q4 2018$39,000
-11.4%
3,400
+30.8%
0.02%
+5.6%
Q3 2018$44,000
+63.0%
2,600
+36.8%
0.02%
+50.0%
Q2 2018$27,000
+17.4%
1,900
+58.3%
0.01%
+9.1%
Q1 2018$23,000
+187.5%
1,200
+140.0%
0.01%
+175.0%
Q4 2017$8,0005000.00%
Other shareholders
SANGAMO THERAPEUTICS INC shareholders Q4 2017
NameSharesValueWeighting ↓
Alexandria Capital, LLC 916,153$8,740,0001.27%
Casdin Capital, LLC 1,080,000$10,303,0001.13%
Rhenman & Partners Asset Management AB 843,957$8,051,0000.94%
WASATCH ADVISORS LP 6,437,908$61,418,0000.67%
BB BIOTECH AG 2,650,000$25,281,0000.64%
Trellus Management Company, LLC 30,000$286,0000.54%
Opus Point Partners Management, LLC 33,529$320,0000.43%
SECTOR GAMMA AS 238,857$2,279,0000.36%
Leisure Capital Management 37,656$359,0000.30%
Ceeto Capital Group, LLC 41,000$391,0000.29%
View complete list of SANGAMO THERAPEUTICS INC shareholders